Exhibit 99.1
CureVac N.V., Tübingen, Germany
Annual General Meeting of Shareholders, June 24, 2021
Voting results – Overview
Agenda Item 3 | Adoption of the annual accounts over the financial year 2020 - accepted | |
139.848.106
| Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
139.701.145 | Yes votes | 99.9 % of the valid votes cast |
5.162 | No votes | 0.0 % of the valid votes cast |
Agenda Item 5 | Appointment of Mr. Antony Blanc as managing director - accepted | |
139.848.260 | Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
139.828.818 | Yes votes | 99.9 % of the valid votes cast |
10.469 | No votes | 0.0 % of the valid votes cast |
Agenda Item 6 | Appointment of Mr. Klaus Edvardsen as managing director - accepted | |
139.848.106 | Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
139.828.984 | Yes votes | 99.9 % of the valid votes cast |
10.353 | No votes | 0.0 % of the valid votes cast |
Agenda Item 7 | Re-appointment of Mr. Pierre Kemula as managing director - accepted | |
139.848.106 | Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
139.828.965 | Yes votes | 99.9 % of the valid votes cast |
10.093 | No votes | 0.0 % of the valid votes cast |
Agenda Item 9 | Equity award to Mr. Jean Stéphenne as compensation for his services as supervisory director - accepted | |
139.848.106 | Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
109.114.552 | Yes votes | 78.0 % of the valid votes cast |
30.681.462 | No votes | 21.9 % of the valid votes cast |
1 |
CureVac N.V., Tübingen, Germany
Annual General Meeting of Shareholders, June 24, 2021
Agenda Item 10 | Equity award to Mr. Ralf Clemens as compensation for his services as supervisory director – accepted | |
139.848.106 | Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
109.312.264 | Yes votes | 78.1 % of the valid votes cast |
30.483.567 | No votes | 21.8 % of the valid votes cast |
Agenda Item 11 | Release of managing directors from liability for the exercise of their duties during the financial year 2020 - accepted | |
139.848.106 | Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
139.612.894 | Yes votes | 99.9 % of the valid votes cast |
86.005 | No votes | 0.0 % of the valid votes cast |
Agenda Item 12 | Release of supervisory directors from liability for the exercise of their duties during the financial year 2020 - accepted | |
139.847.836 | Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
139.612.426 | Yes votes | 99.9 % of the valid votes cast |
88.620 | No votes | 0.0 % of the valid votes cast |
Agenda Item 13 | Authorization of the management board to acquire shares (or depository receipts for shares) in the Company's capital – rejected | |
139.848.106 | Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
21.994.434 | Yes votes | 15.7 % of the valid votes cast |
117.824.940 | No votes | 84.2 % of the valid votes cast |
Agenda Item 14 | Compensation of supervisory directors - accepted | |
139.847.806 | Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
109.934.665 | Yes votes | 78.6 % of the valid votes cast |
29.894.951 | No votes | 21.3 % of the valid votes cast |
2 |
CureVac N.V., Tübingen, Germany
Annual General Meeting of Shareholders, June 24, 2021
Agenda Item 15 | Appointment of the external auditor for the financial year 2022 - accepted | |
139.848.106 | Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
139.833.679 | Yes votes | 99.9 % of the valid votes cast |
5.990 | No votes | 0.0 % of the valid votes cast |
3 |